Cytokine Profile in Autism Spectrum Disorders in Children

Journal of Molecular Neuroscience

Volumn 61, Issue 1, 2017, Pages 1-7

  Bryn, Vesna ^a   Aass, Hans Christian Dalsbotten ^b   Skjeldal, Ola H ^c   Isaksen, Jørn ^a   Saugstad, Ola Didrik ^d   Ormstad, Heidi ^e  

^a INNLANDET HOSPITAL TRUST   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF SOUTH EASTERN NORWAY   (Norway)

Author keywords

Autism spectrum disorders; Cytokine profile

Indexed keywords

CXCL1 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; TUMOR NECROSIS FACTOR; INTERLEUKIN DERIVATIVE;

ARTICLE; ASPERGER SYNDROME; AUTISM; CHILD; CHILDHOOD; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAGNOSIS RELATED GROUP; EPIDEMIOLOGICAL DATA; FEMALE; HISTOPATHOLOGY; HUMAN; INTELLECTUAL IMPAIRMENT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NORWAY; PATHOPHYSIOLOGY; RETT SYNDROME; SCHOOL CHILD; SERUM; ADOLESCENT; BLOOD; CASE CONTROL STUDY;

ADOLESCENT; AUTISM SPECTRUM DISORDER; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; INTERLEUKINS; MALE;

EID: 84991087031     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-016-0847-z     Document Type: Article

References (42)

1. Ashwood P et al (2011a) Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 25:40–5
2. Ashwood P et al (2011b) Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J Neuroimmunol 232:196–9
3. Atladottir HO et al (2009) Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics 124:687–94
4. Baird G et al (2006) Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet 368:210–5
5. Bauer S, Kerr BJ, Patterson PH (2007) The neuropoietic cytokine family in development, plasticity, disease and injury. Nat Rev Neurosci 8:221–32
6. Braunschweig D, Van de Water J (2012) Maternal autoantibodies in autism. Arch Neurol 69:693–9
7. Braunschweig D et al (2008) Autism: maternally derived antibodies specific for fetal brain proteins. Neurotoxicology 29:226–31
8. Brown AS (2012) Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism. Dev Neurobiol 72:1272–6
9. Coleman M, Gillberg C, Gillberg, C.B.o.t.a.s (2012). The autisms, Vol., Oxford University Press, New York; Oxford
10. Comi AM et al (1999) Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol 14:388–94
11. Cordeiro CN, Tsimis M, Burd I (2015) Infections and brain development. Obstet Gynecol Surv 70:644–55
12. Croen LA et al (2005) Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case–control study. Arch Pediatr Adolesc Med 159:151–7
13. Croen LA et al (2008) Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study. Biol Psychiatry 64:583–8
14. Croonenberghs J et al (2002) Activation of the inflammatory response system in autism. Neuropsychobiology 45:1–6
15. Dantzer R (2004) Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur J Pharmacol 500:399–411
16. Emanuele E et al (2010) Low-grade endotoxemia in patients with severe autism. Neurosci Lett 471:162–5
17. Fombonne E (2009) Epidemiology of pervasive developmental disorders. Pediatr Res 65:591–8
18. Gesundheit B et al (2013) Immunological and autoimmune considerations of autism spectrum disorders. J Autoimmun 44:1–7
19. Isaksen J et al (2012) Observed prevalence of autism spectrum disorders in two Norwegian counties. Eur J Paediatr Neurol 16:592–8
20. Isaksen J et al (2013) Children with autism spectrum disorders—the importance of medical investigations. Eur J Paediatr Neurol 17:68–76
21. Jarskog LF et al (1997) Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro. Int J Dev Neurosci 15:711–6
22. Levy SE, Mandell DS, Schultz RT (2009) Autism Lancet 374:1627–38
23. Masi A, Quintana, DS, (2015). Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. 20, 440–6
24. Mead J, Ashwood P (2015) Evidence supporting an altered immune response in ASD. Immunol Lett 163:49–55
25. Meyer U, Feldon J, Yee BK (2009) A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr Bull 35:959–72
26. Mouridsen SE et al (2007) Autoimmune diseases in parents of children with infantile autism: a case–control study. Dev Med Child Neurol 49:429–32
27. Mousa A et al (1999) Human first trimester forebrain cells express genes for inflammatory and anti-inflammatory cytokines. Cytokine 11:55–60
28. Napolioni V et al (2013) Plasma cytokine profiling in sibling pairs discordant for autism spectrum disorder. J Neuroinflammation 10:38
29. Nawa H, Takei N (2006) Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines. Neurosci Res 56:2–13
30. Nordahl CW et al (2013) Maternal autoantibodies are associated with abnormal brain enlargement in a subgroup of children with autism spectrum disorder. Brain Behav Immun 30:61–5
31. Onore C, Careaga M, Ashwood P (2012) The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun 26:383–92
32. Persico AM, Bourgeron T (2006) Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci 29:349–58
33. Rogers SJ (2004) Developmental regression in autism spectrum disorders. Ment Retard Dev Disabil Res Rev 10:139–43
34. Rose D, Ashwood P (2014) Potential cytokine biomarkers in autism spectrum disorders. Biomark Med 8:1171–81
35. Singer HS et al (2008) Antibodies against fetal brain in sera of mothers with autistic children. J Neuroimmunol 194:165–72
36. Singh VK et al (1991) Changes of soluble interleukin-2, interleukin-2 receptor, T8 antigen, and interleukin-1 in the serum of autistic children. Clin Immunol Immunopathol 61:448–55
37. Spence SJ, Schneider MT (2009) The role of epilepsy and epileptiform EEGs in autism spectrum disorders. Pediatr Res 65:599–606
38. Suzuki K et al (2011) Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. PLoS One 6, e20470
39. Sweeten TL et al (2004) High nitric oxide production in autistic disorder: a possible role for interferon-gamma. Biol Psychiatry 55:434–7
40. Taylor LE, Swerdfeger AL, Eslick GD (2014) Vaccines are not associated with autism: an evidence-based meta-analysis of case–control and cohort studies. Vaccine 32:3623–9
41. Xu N, Li X, Zhong Y (2015) Inflammatory cytokines: potential biomarkers of immunologic dysfunction in autism spectrum disorders. Mediat Inflamm 2015:531518
42. Zimmerman AW et al (2005) Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr Neurol 33:195–201